Q2 2025 Holdings
Filed 2025-08-13 | 13 holdings | $359.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BridgeBio Pharma Inc. (Bbio)(BBIO) | COM | 10806X102 | $262.0M | 6,068,125 | 72.9% |
| Verona Pharma plc (Vrna)(VRNA) | SPONSORED ADS | 925050106 | $58.2M | 615,352 | 16.2% |
| Syndax Pharmaceuticals, Inc. (Sndx)(SNDX) | COM | 87164F105 | $12.3M | 1,316,806 | 3.4% |
| Monte Rosa Therapeutics Inc (Glue)(GLUE) | COM | 61225M102 | $6.6M | 1,472,331 | 1.8% |
| Bicara Therapeutics Inc. (Bcax)(BCAX) | COM | 055477103 | $5.3M | 568,919 | 1.5% |
| Nuvation Bio Inc. (Nuvb)(NUVB) | COM CL A | 67080N101 | $5.0M | 2,541,009 | 1.4% |
| Biomea Fusion Inc (Bmea)(BMEA) | COM | 09077A106 | $3.7M | 2,048,757 | 1.0% |
| Compass Pathways Plc (Cmps)(CMPS) | SPONSORED ADS | 20451W101 | $3.4M | 1,198,418 | 0.9% |
| Elevation Oncology Inc (Elev) | COM | 28623U101 | $1.0M | 2,834,910 | 0.3% |
| CalciMedica, Inc. (Calc)(CALC) | COM NEW | 38942Q202 | $833.8K | 521,114 | 0.2% |
| Aclaris Therapeutics Inc (Acrs)(ACRS) | COM | 00461U105 | $616.9K | 434,455 | 0.2% |
| Marker Therapeutics, Inc. (Mrkr)(MRKR) | COM NEW | 57055L206 | $497.8K | 325,370 | 0.1% |
| OnKure Therapeutics, Inc. (Okur)(OKUR) | COM CL A | 68277Q105 | $211.8K | 88,607 | 0.1% |